FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Mallinckrodt Thallous Chloride Tl 201 Injection Recall

Thallous Chloride Tl 201 Injection, Diagnostic Sterile, Non-Pyrogenic Solution, a) 2

Mallinckrodt Inc · Hazelwood, MO

Risk level
Class III
Reported by FDA
Oct 3, 2012
Recall ID
D-1692-2012
Check your lot numberHow we source this data

Summary

Mallinckrodt recalled Thallous Chloride Tl 201 Injection starting Jul 30, 2012. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1692-2012 on Oct 3, 2012. Reason: Labeling: Correct Labeled Product Miscart/Mispack: labels on outer containers do not match labels on vials (the correct label). Status: Terminated.

Why it was recalled

Labeling: Correct Labeled Product Miscart/Mispack: labels on outer containers do not match labels on vials (the correct label)

Product description

Thallous Chloride Tl 201 Injection, Diagnostic Sterile, Non-Pyrogenic Solution, a) 2.8 mL (NDC 0019N12028) b) 6.3ml (NDC 0019N12063) For Intravenous Administration, each milliliter contains 37 MBq (1 mCi) Thallous Chloride Tl 201 (no carrier added) at date and time of calibration, 9 mg sodium chloride and 0.9% (v/v) benzyl alcohol as a preservative, RX, Mallinckrodt Inc., St. Louis, MO 63134

Lot numbers, UPCs & expiration codes

Lot 120-2686, exp. 8/2/12.

Where it was sold

AZ, CT, MO, MS, PA, FL, WA, NC, CA, TX, OK

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1692-2012
Classification
Class III
Status
Terminated
Recall initiated
Jul 30, 2012
FDA report date
Oct 3, 2012
Quantity
12/2.8mCi-vials and 12/6.3mCi-vials
Recall type
Voluntary: Firm initiated
Recalling firm
Mallinckrodt Inc

Original FDA data

Every field from FDA enforcement report D-1692-2012, exactly as published.

Show all FDA fields
City
Hazelwood
State
MO
Status
Terminated
Country
United States
Event ID
62696
Address
675 James S McDonnell Blvd
Code information
Lot 120-2686, exp. 8/2/12.
Postal code
63042-2301
Report date
Oct 3, 2012
Product type
Drugs
Recall number
D-1692-2012
Classification
Class III
Recalling firm
Mallinckrodt Inc
Product quantity
12/2.8mCi-vials and 12/6.3mCi-vials
Termination date
Nov 16, 2012
Reason for recall
Labeling: Correct Labeled Product Miscart/Mispack: labels on outer containers do not match labels on vials (the correct label)
Voluntary / mandated
Voluntary: Firm initiated
Product description
Thallous Chloride Tl 201 Injection, Diagnostic Sterile, Non-Pyrogenic Solution, a) 2.8 mL (NDC 0019N12028) b) 6.3ml (NDC 0019N12063) For Intravenous Administration, each milliliter contains 37 MBq (1 mCi) Thallous Chloride Tl 201 (no carrier added) at date and time of calibration, 9 mg sodium chloride and 0.9% (v/v) benzyl alcohol as a preservative, RX, Mallinckrodt Inc., St. Louis, MO 63134
Distribution pattern
AZ, CT, MO, MS, PA, FL, WA, NC, CA, TX, OK
Recall initiation date
Jul 30, 2012
Initial firm notification
FAX
Center classification date
Sep 25, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1692-2012, published Oct 3, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls